12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga·03/13/2026 21:05:56
Listen to the news
Gainers
Ensysce Biosciences (NASDAQ:ENSC) stock rose 6.7% to $0.43 during Friday's after-market session. The market value of their outstanding shares is at $1.5 million.
Inovio Pharmaceuticals (NASDAQ:INO) shares rose 6.02% to $1.76. The market value of their outstanding shares is at $115.4 million. As per the news, the Q4 earnings report came out yesterday.
Traws Pharma (NASDAQ:TRAW) shares moved upwards by 6.0% to $2.12. The company's market cap stands at $16.1 million.
Akanda (NASDAQ:AKAN) shares moved upwards by 5.96% to $0.87. The market value of their outstanding shares is at $1.7 million.
Neuraxis (AMEX:NRXS) stock moved upwards by 5.83% to $7.26. The market value of their outstanding shares is at $69.0 million.
Firefly Neuroscience (NASDAQ:AIFF) shares rose 5.81% to $2.91. The company's market cap stands at $24.7 million.
Losers
Bio Green Med Solution (NASDAQ:BGMS) shares declined by 7.3% to $0.77 during Friday's after-market session. The market value of their outstanding shares is at $4.6 million.
Basel Medical Group (NASDAQ:BMGL) stock decreased by 7.18% to $0.57. The company's market cap stands at $11.2 million.
SciSparc (NASDAQ:SPRC) stock decreased by 6.89% to $4.06. The market value of their outstanding shares is at $24.0 million.
Tivic Health Systems (NASDAQ:TIVC) shares declined by 6.33% to $0.88. The market value of their outstanding shares is at $1.6 million.
Modular Medical (NASDAQ:MODD) shares declined by 6.11% to $0.21. The market value of their outstanding shares is at $31.3 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.